Indicadores financieros
- Market Capitalization 428.36 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.94
Relación precio/flujo de caja
100.37
Tickers relacionados
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2907 | YDES YD Bio Limited - Ordinary Shares | 6.34 USD | +3.93% | +6.02% | +67.28% | -65.73% | 448.80 M USD | ||
| 2913 | NGNE Neurogene Inc. - Common Stock | 21.75 USD | +0.88% | -15.04% | -37.93% | -26.07% | 435.25 M USD | ||
| 2924 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.51 USD | +0.80% | -0.40% | -9.39% | +2.03% | 434.59 M USD | ||
| 2934 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.67 USD | +3.09% | -6.70% | -14.36% | +0.60% | 444.49 M USD |